| Name | Title | Contact Details |
|---|
Hinge Health is pioneering the world`s most patient-centered Digital Musculoskeletal (MSK) Clinic™. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, opioid use, and surgeries by pairing advanced wearable sensors and computer vision technology with a comprehensive Clinical Care Team with doctors of physical therapy, physicians, board-certified health coaches, and more. Hinge Health`s Digital MSK Clinic is connected with 750,000+ in-person providers and enables real-time interventions for proven medical claims reduction. Available to millions of members, Hinge Health is the #1 Digital MSK Clinic with 500+ health plans and employers customers, including Boeing, Salesforce, and US Foods. Hinge Health has raised $826M to date with offices across San Francisco, Austin, Chicago, Denver, Minneapolis, Portland, Seattle and more.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Native American Connections is a non-profit organization that provides Native American culturally appropriate behavioral health, affordable housing, and community development services in Arizona.
Central Pennsylvania Blood Bank is a Hummelstown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Asset Management Inc is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.